T. Doskas

发表

An electroglottographical analysis-based discriminant function model differentiating multiple sclerosis patients from healthy controls

G. Vavougios, T. Doskas, K. Konstantopoulos, 2018, Neurological Sciences.

Stroke risk in multiple sclerosis: a critical appraisal of the literature

E. Dardiotis, G. Vavougios, K. Vadikolias, 2022, The International journal of neuroscience.

Clinical utility of the months backward test in patients with vascular cognitive impairment

T. Doskas, Constantinos Kormas, 2020, Neurological Sciences.

An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients

A. Stefani, R. Krüger, A. Antonini, 2017, Advances in Therapy.

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

P. Mitsias, G. Hadjigeorgiou, N. Grigoriadis, 2022, Neurology and Therapy.

Double hit viral parasitism, polymicrobial CNS residency and perturbed proteostasis in Alzheimer's disease: A data driven, in silico analysis of gene expression data.

K. Gourgoulianis, S. Zarogiannis, G. Vavougios, 2020, Molecular immunology.

Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA)

G. Tsivgoulis, E. Dardiotis, G. Hadjigeorgiou, 2014, PloS one.

Neurocognitive impairment and social cognition in multiple sclerosis

G. Vavougios, T. Doskas, Constantinos Kormas, 2021, The International journal of neuroscience.

Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients

G. Vavougios, T. Doskas, Konstantinos T. Ntoskas, 2020, Medical Hypotheses.

Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.

G. Garinis, N. Ktistakis, D. Boumpas, 2020, Cell metabolism.

Leukoaraiosis as a Predictor of Depression and Cognitive Impairment among Stroke Survivors: A Systematic Review

F. Christidi, D. Tsiptsios, N. Aggelousis, 2023, Neurology international.

Repetitive Transcranial Magnetic Stimulation in the Treatment of Alzheimer’s Disease and Other Dementias

G. Nasios, E. Dardiotis, D. Bogdanos, 2021, Healthcare.

Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer’s disease

K. Gourgoulianis, S. Zarogiannis, G. Vavougios, 2021, Brain, Behavior, & Immunity - Health.

A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study

P. Mitsias, D. Mitsikostas, D. Papadopoulos, 2021, Advances in Therapy.

The Dimensionality of the Multidimensional Fatigue Inventory (MFI-20) Derived From Healthy Adults and Patient Subpopulations: A Challenge for Clinicians

P. Theodorou, D. Bakalidou, T. Doskas, 2022, Cureus.

Demyelination with autoimmune features (DAF): A distinct clinical entity? Results from a longitudinal cohort.

M. Papathanasiou, D. Nikolopoulos, D. Boumpas, 2021, Rheumatology.

Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α–dependent pathways

F. Sallusto, F. Quintana, P. Wei, 2020, Proceedings of the National Academy of Sciences.

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

P. Vermersch, J. López-arrieta, O. Hermine, 2023, Alzheimer's Research & Therapy.

Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia.

P. Vogazianos, T. Doskas, K. Konstantopoulos, 2016, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod

E. Dardiotis, N. Grigoriadis, D. Mitsikostas, 2023, Advances in therapy.

Identification of a prospective early motor progression cluster of Parkinson's disease: Data from the PPMI study

L. Stefanis, S. Zarogiannis, K. Krogfelt, 2018, Journal of the Neurological Sciences.

Social Cognition Impairments in Association to Clinical, Cognitive, Mood, and Fatigue Features in Multiple Sclerosis: A Study Protocol

F. Christidi, D. Tsiptsios, G. Vavougios, 2023, Neurology international.

Probiotics’ Effects in the Treatment of Anxiety and Depression: A Comprehensive Review of 2014–2023 Clinical Trials

D. Tsiptsios, T. Doskas, A. Serdari, 2024, Microorganisms.

Neurocognitive Impairment and Social Cognition in Parkinson’s Disease Patients

G. Nasios, E. Dardiotis, D. Tsiptsios, 2024, Neurology international.

An electroglottographical analysis-based discriminant function model differentiating multiple sclerosis patients from healthy controls

G. Vavougios, T. Doskas, K. Konstantopoulos, 2018, Neurological Sciences.

Validity and Reliability of the Lower Extremity Motor Coordination Test (LEMOCOT) in Patients with Multiple Sclerosis

G. Koumantakis, T. Doskas, Vassiliki Sakellari, 2024, Applied Sciences.

SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease

T. Doskas, P. Foka, T. Mavridis, 2024, Current issues in molecular biology.